Escalon Medical Corp. Stock Other OTC
Equities
ESMC
US2960743050
Advanced Medical Equipment & Technology
Financials (USD)
Sales 2022 | 10.7M | Sales 2023 | 12.18M | Capitalization | 1.85M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 0.14 x |
Net Debt 2022 | 611K | Net Debt 2023 | 205 | EV / Sales 2023 | 0.15 x |
P/E ratio 2022 |
-28
x | P/E ratio 2023 |
8.37
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.1% |
Managers | Title | Age | Since |
---|---|---|---|
Richard DePiano
CEO | Chief Executive Officer | 58 | 00-10-31 |
Mark Wallace
DFI | Director of Finance/CFO | 55 | 96-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Napolitano
BRD | Director/Board Member | 61 | 02-12-31 |
Richard DePiano
CEO | Chief Executive Officer | 58 | 00-10-31 |
David Jacovini
BRD | Director/Board Member | 48 | 18-02-12 |
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |